Rate My Professor Chris Gale

Professor Chris Gale is Professor of Neonatal Medicine in the School of Public Health, Faculty of Medicine at Imperial College London. He earned an MBBS from Newcastle University, an MSc, and a PhD in Neonatal Medicine from Imperial College London between 2009 and 2013. As a Medical Research Council Clinician Scientist, he serves as Honorary Consultant Neonatologist at Chelsea and Westminster NHS Foundation Trust and was appointed Deputy Director of the Imperial Clinical Trials Unit in 2025. Gale leads several large pragmatic international neonatal trials, including the WHEAT trial, focused on improving outcomes for preterm babies and sick newborns through clinical research and practice. His career emphasizes observational studies and trials to reduce perinatal brain injuries, and he leads the national perinatal brain injury surveillance programme for the Department of Health and Social Care in England.

Gale's research interests center on neonatal medicine, leveraging routinely collected clinical data to enhance neonatal care, exploring the influence of early life events on later health, and applying evidence-based medicine in neonatal practice. He has secured funding from MRC and NIHR, including Clinician Scientist and Clinical Trials Fellowships. Key publications include 'Neonatal brain injuries in England' (Archives of Disease in Childhood - Fetal and Neonatal Edition, 2018), 'Development of a core outcome set for neonatal research' (Archives of Disease in Childhood - Fetal and Neonatal Edition, 2020), and 'Core outcome sets in neonatal medicine' (Archives of Disease in Childhood - Education & Practice Edition, 2018). With over 10,000 citations on Google Scholar, his work has significant impact. Gale chairs the NIHR Research for Patient Benefit London Regional Funding Panel, coordinates academic training across the London School of Paediatrics, and is President of the Neonatal Society.